Cargando…
Safety and Preliminary Efficacy of a Novel Host-Modulatory Therapy for Reducing Gingival Inflammation
BACKGROUND: Periodontal disease is among the sixth most common inflammatory diseases worldwide with high risk to promote complications from other inflammatory diseases including diabetes, cardiovascular disease and Alzheimer’s Disease. Failure of active resolution of inflammation pathways is implica...
Autores principales: | Hasturk, Hatice, Schulte, Fabian, Martins, Melissa, Sherzai, Homa, Floros, Constantinos, Cugini, MaryAnn, Chiu, Chung-Jung, Hardt, Markus, Van Dyke, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475270/ https://www.ncbi.nlm.nih.gov/pubmed/34589083 http://dx.doi.org/10.3389/fimmu.2021.704163 |
Ejemplares similares
-
Use of amnion‐derived cellular cytokine solution for the treatment of gingivitis: A 2‐week safety, dose‐ranging, proof‐of‐principle randomized trial
por: Hasturk, Hatice, et al.
Publicado: (2021) -
Maresin-1 and Resolvin E1 Promote Regenerative Properties of Periodontal Ligament Stem Cells Under Inflammatory Conditions
por: Albuquerque-Souza, Emmanuel, et al.
Publicado: (2020) -
Oral Inflammatory Diseases and Systemic Inflammation: Role of the Macrophage
por: Hasturk, Hatice, et al.
Publicado: (2012) -
Obesity and Dental Decay: Inference on the Role of Dietary Sugar
por: Goodson, J. Max, et al.
Publicado: (2013) -
Three‐Dimensional Humanized Model of the Periodontal Gingival Pocket to Study Oral Microbiome
por: Adelfio, Miryam, et al.
Publicado: (2023)